305 related articles for article (PubMed ID: 37265798)
41. TAM Receptor Inhibition-Implications for Cancer and the Immune System.
Aehnlich P; Powell RM; Peeters MJW; Rahbech A; Thor Straten P
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801886
[TBL] [Abstract][Full Text] [Related]
42. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival.
van Ginkel PR; Gee RL; Shearer RL; Subramanian L; Walker TM; Albert DM; Meisner LF; Varnum BC; Polans AS
Cancer Res; 2004 Jan; 64(1):128-34. PubMed ID: 14729616
[TBL] [Abstract][Full Text] [Related]
43. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
[TBL] [Abstract][Full Text] [Related]
44. Gas6 expression and Tyrosine kinase Axl Sky receptors: Their relation with tumor stage and grade in patients with bladder cancer.
Akgül M; Baykan Ö; Çağman Z; Özyürek M; Tinay İ; Akbal C; Uras F; Türkeri L
Arch Ital Urol Androl; 2021 Jun; 93(2):148-152. PubMed ID: 34286546
[TBL] [Abstract][Full Text] [Related]
45. Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance.
Xiong R; Sun XX; Wu HR; Xu GW; Wang GX; Sun XH; Xu MQ; Xie MR
Thorac Cancer; 2020 Jan; 11(1):156-165. PubMed ID: 31777195
[TBL] [Abstract][Full Text] [Related]
46. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
Ekman C; Stenhoff J; Dahlbäck B
J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
[TBL] [Abstract][Full Text] [Related]
47. PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma.
Hedrich V; Breitenecker K; Ortmayr G; Pupp F; Huber H; Chen D; Sahoo S; Jolly MK; Mikulits W
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173882
[TBL] [Abstract][Full Text] [Related]
48. From MASH to HCC: the role of Gas6/TAM receptors.
Apostolo D; Ferreira LL; Vincenzi F; Vercellino N; Minisini R; Latini F; Ferrari B; Burlone ME; Pirisi M; Bellan M
Front Immunol; 2024; 15():1332818. PubMed ID: 38298195
[TBL] [Abstract][Full Text] [Related]
49. The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology.
Yanagita M
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):465-70. PubMed ID: 15199298
[TBL] [Abstract][Full Text] [Related]
50. Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome.
Morales A; Rojo Rello S; Cristóbal H; Fiz-López A; Arribas E; Marí M; Tutusaus A; de la Cal-Sabater P; Nicolaes GAF; Ortiz-Pérez JT; Bernardo D; García de Frutos P
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33810394
[TBL] [Abstract][Full Text] [Related]
51. Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression.
He L; Lei Y; Hou J; Wu J; Lv G
Onco Targets Ther; 2020; 13():5901-5911. PubMed ID: 32606800
[TBL] [Abstract][Full Text] [Related]
52. Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.
Ishikawa M; Sonobe M; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Date H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S467-76. PubMed ID: 23242819
[TBL] [Abstract][Full Text] [Related]
53. Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients.
Rizzi M; Tonello S; D'Onghia D; Sainaghi PP
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674471
[TBL] [Abstract][Full Text] [Related]
54. AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
Seike M; Kim CH; Zou F; Noro R; Chiba M; Ishikawa A; Κunugi S; Kubota K; Gemma A
Oncol Rep; 2017 Jun; 37(6):3261-3269. PubMed ID: 28440492
[TBL] [Abstract][Full Text] [Related]
55. AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew.
Auyez A; Sayan AE; Kriajevska M; Tulchinsky E
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638349
[TBL] [Abstract][Full Text] [Related]
56. Gas6/Axl signaling attenuates alveolar inflammation in ischemia-reperfusion-induced acute lung injury by up-regulating SOCS3-mediated pathway.
Peng CK; Wu CP; Lin JY; Peng SC; Lee CH; Huang KL; Shen CH
PLoS One; 2019; 14(7):e0219788. PubMed ID: 31318922
[TBL] [Abstract][Full Text] [Related]
57. An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.
Kariolis MS; Miao YR; Jones DS; Kapur S; Mathews II; Giaccia AJ; Cochran JR
Nat Chem Biol; 2014 Nov; 10(11):977-83. PubMed ID: 25242553
[TBL] [Abstract][Full Text] [Related]
58. Growth Arrest-Specific 6 Enhances the Suppressive Function of CD4
Zhao GJ; Zheng JY; Bian JL; Chen LW; Dong N; Yu Y; Hong GL; Chandoo A; Yao YM; Lu ZQ
Mediators Inflamm; 2017; 2017():6848430. PubMed ID: 28270700
[No Abstract] [Full Text] [Related]
59. Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.
Lee YJ; Lim T; Han MS; Lee SH; Baek SH; Nan HY; Lee C
Oncol Rep; 2017 Feb; 37(2):1219-1226. PubMed ID: 28035396
[TBL] [Abstract][Full Text] [Related]
60. Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma.
Hattori S; Kikuchi E; Kosaka T; Miyazaki Y; Tanaka N; Miyajima A; Mikami S; Oya M
Ann Surg Oncol; 2016 Feb; 23(2):663-70. PubMed ID: 26350366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
